VHH Antibody discovery

SMART

VHH ANTIBODY

DISCOVERY

 

1014 functional possibilities. Zero compromise

Ribosomal display diversity combined with phage display precision

in one integrated VHH discovery platform

Smart VHH Antibody Discovery

Cortalix offers cutting-edge VHH antibody discovery & development services through a unique, dual-platform approach, combining the massive functional diversity of ribosomal display with the battle-tested robustness of phage display:

  • SYNTHETIC LIBRARIES: animal-free, rapid, and built for scale. Powered by ribosomal display with a functional diversity of up to 1014, enabling deep coverage of sequence space, ideal for fast screening, modular multispecific formats, or high-throughput projects.
  • IMMUNE LIBRARIES: derived from llama immunizations and screened via phage display. Providing high natural affinity and deep epitope coverage for complex or challenging targets.

Our hybrid platform, ribosomal display for breadth, phage display for precision, gives you the flexibility to choose the best discovery route for each project, with seamless downstream integration.

Whether you’re developing a diagnostic, therapeutic, or analytical research tool, we support you all the way, with expert services in CDR grafting, humanization, affinity maturation, conjugation, and more.

What We Offer

Discovery via Immune & Synthetic Libraries

Choose ribosomal display (1014 diversity, animal-free), immune library phage display, or both, matched to your target and strategy

Lead Optimization

CDR grafting, humanization, stability profiling, affinity maturation

Engineering & Conjugation

Custom design: Fc-fusion, chelation, fluorophores, nanobody-drug-conjugates, linkers, toxins, multispecifics

Preclinical Readiness

Expression, purification, in vitro profiling, Radiopharmaceutical and CAR-T optimization, GMP transfer support

Why Choose Cortalix

VHH nanobody icon at cortalix text, why choose us
Unmatched Library Diversity: Ribosomal display delivers up to 1014 functional variants, orders of magnitude beyond conventional phage display libraries from other VHH providers.
VHH nanobody icon at cortalix text, why choose us

Animal-Free Options: Synthetic library track is fully animal-free

VHH nanobody icon at cortalix text, why choose us

Deep Binding Potential: Immune libraries offer strong, specific VHHs

VHH nanobody icon at cortalix text, why choose us

Full Engineering Support: From discovery to preclinical applications

VHH nanobody icon at cortalix text, why choose us

Experienced Team: Decades of combined VHH antibody development expertise

Contact Us

Let’s find your best VHH Antibody strategy. Contact us today for a free intake session. We’ll help map the best route from target to lead candidate.

EU logo for cortalix the VHH nanobody company in the netherlands
SNN Noord Nederland logo for cortalix the VHH nanobody company in the netherlands
Eureka logo for cortalix the VHH nanobody company in the netherlands
Eurostars logo for cortalix the VHH nanobody company in the netherlands
Rabobank logo for cortalix the VHH nanobody company in the netherlands
Future Tech Ventures logo for cortalix the VHH nanobody company in the netherlands
University Medical Center Groningen logo for cortalix the VHH nanobody company in the netherlands
University of Groningen logo for cortalix the VHH nanobody company in the netherlands

Contact Us

If you would like to know more about our organization, or would like to know how we can support your projects, please complete the contact form. We will contact you shortly.